Miltefosine, sold under the trade name Impavido among others, is a medication mainly used to treat leishmaniasis and free-living amoeba infections such as Naegleria fowleri and Balamuthia mandrillaris. [4]

Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. How do people get infected with Leishmania parasites? The main way is through the bite of infected female phlebotomine sand flies.

2024年6月14日 · Miltefosine is used to treat leishmaniasis affecting the skin, internal organs (such as the liver, spleen or bone marrow), and mucous membranes (nose, mouth, and throat). Miltefosine may also be used for purposes not listed in this medication guide.

2024年1月31日 · Miltefosine is used to treat certain types of leishmaniasis, such as visceral leishmaniasis (affects the internal organs), cutaneous leishmaniasis (affects the skin), or mucosal leishmaniasis (affects the nose, mouth, or throat). This medicine is available only with your doctor's prescription.

2015年2月17日 · Miltefosine is a broad spectrum antimicrobial, anti-leishmanial, phospholipid drug that was originally developed in the 1980s as an anti-cancer agent. It is currently the only recognized oral agent used to treat visceral, cutaneous, and mucosal forms of leishmaniasis, a neglected tropical disease.

Miltefosine is used to treat a certain infection called leishmaniasis. It works by stopping the growth of certain parasites.

MILTEFOSINE (mill TEFF oh seen) is an antiprotozoan agent. It is used to treat certain kinds of parasite infections. It will not work for colds, flu, or other viral infections.

Miltefosine is an antiprotozoal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of leishmaniasis. Leishmaniasis can be an opportunistic infection (OI) of HIV.

Miltefosine is a prescription medication used for the treatment of leishmaniasis. Miltefosine is available under various brand names: Impavido

Miltefosine is a broad spectrum antimicrobial, anti-leishmanial, phospholipid drug that was originally developed in the 1980s as an anti-cancer agent. It is currently the only recognized oral agent used to treat visceral, cutaneous, and mucosal forms of …